期刊文献+

银杏叶片联合阿托伐他汀干预动脉粥样斑块形成的临床效果观察 被引量:2

Clinical effect of ginkgo biloba leaf tablets combined with atorvastatin on the treatment of atherosclerotic plaque formation
下载PDF
导出
摘要 目的研究银杏叶片联合阿托伐他汀干预动脉粥样斑块形成的临床疗效。方法选择148例高脂血症伴动脉粥样硬化患者,应用随机数表法分为对照组和观察组各74例。对照组患者口服阿托伐他汀治疗,观察组患者口服银杏叶片+阿托伐他汀联合治疗。比较治疗前后2组血脂指标及颈动脉内膜-中膜厚度改善情况以及治疗期间药物不良反应发生比例。结果2组治疗后HDL-C水平均显著高于治疗前,LDL-C、TG、TC等水平均显著低于治疗前,观察组治疗后HDL-C水平均显著高于对照组,LDL-C、TG、TC等水平均显著低于对照组(P<0.05);2组治疗后颈动脉内膜-中膜厚度均显著低于治疗前,观察组治疗后颈动脉内膜-中膜厚度显著低于对照组(P<0.05);2组不良反应发生率比较,差异无统计学意义(P>0.05)。结论银杏叶片与阿托伐他汀联合治疗可有效调节血脂水平,预防动脉粥样斑块形成,促进动脉粥样斑块消退,改善血管功能,且安全性高。 Objective To study the clinical effect of ginkgo biloba leaf tablets combined with atorvastatin in prevention of atherosclerotic plaque formation.Methods A total of 148 patients with hyperlipidemia and atherosclerosis treated in our hospital were randomized into control group and observation group,with 74 cases in each group.The patients in the control group were treated with oral atorvastatin,and the patients in the observation group were treated with Ginkgo biloba leaf tablets in combination with atorvastatin.The levels of serum lipid and carotid intima-media thickness were observed before and after treatment,and the proportion of adverse drug reactions during treatment was observed and compared.Results HDL-C levels of two groups were higher,and LDL-C,TG,TC levels were lower than treatment before.After treatment,the observation group had higher HDL-C levels and lower LDL-C,TG,TC levels than the control group(P<0.05).The intima-media thickness of the carotid artery in the two groups after treatment were lower than treatment before and observation group was lower than the control group(P<0.05).There was no significant difference between the two groups in adverse drug reactions(P>0.05).Conclusion Ginkgo biloba leaves tablets combined with atorvastatin can effectively regulate blood lipid levels,prevent atherosclerotic plaque formation,promote the disappearance of atherosclerotic plaque,and improve vascular function,so it is of high safety.
作者 顾卫青 GU Weiqing(Zhuqiao Community Health Service Center in Pudong New Area,Shanghai,201323)
出处 《实用临床医药杂志》 CAS 2018年第1期35-37,共3页 Journal of Clinical Medicine in Practice
关键词 动脉粥样斑块 银杏叶片 阿托伐他汀 血脂 atherosclerotic plaque ginkgo biloba leaf tablets atorvastatin blood lipids
  • 相关文献

参考文献10

二级参考文献85

  • 1秦彦文,杜兰萍,李晋生,安海梅,何继强,潘晓冬,王绿娅,王伟.降脂灵片对高胆固醇血症患者抗氧化能力的影响[J].中华全科医师杂志,2006,5(1):41-42. 被引量:2
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33022
  • 3牛纪华,王晓萍,徐艳春,席崇,田相同.脂康颗粒治疗高脂血症临床研究[J].山东中医杂志,2007,26(2):103-104. 被引量:9
  • 4柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2117
  • 5中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5221
  • 6Cavallini C,Verdecchia P,Savonitto S,et al.Prognostic value of isolated troponin I elevation after percutaneous coronary intervention[J] .Circ Cardiovasc Interv,2010,3(5):431-435.
  • 7Urbano-Moral JA,Lopez-Haldon JE,Fernandez M,et al.Prognostic value of different serum biomarkers for left ventricular remodelling after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention[J] .Heart,2012,98(15):1153-1159.
  • 8Sardella G,Accapezzato D,Di Roma A,et al.Integrin beta 2-chain (CD18) over-expression on CD+4 T cells and monocytes after ischemia/reperfusion in patients undergoing primary percutaneous revascularization[J] .Int J Immunopathol Pharmacol,2004,17(2):165-170.
  • 9Szwed H.Clinical benefits of trimetazidine in patients with recurrent angina[J] .Coron Artery Dis,2004,15(Suppl 1):S17-S21.
  • 10Labrou A,Giannoglou G,Zioutas D,et al.Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention[J] .Am J Cardiovasc Drugs,2007,7(2):143-150.

共引文献178

同被引文献17

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部